Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Alpelisib × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 10 Neoplasm Metastasis 3 Recurrence 2 Ovarian Neoplasms 2 Lymphatic Abnormalities 2 Lymphangioma, Cystic 2 Lymphangioma 2 Hereditary Sensory and Autonomic Neuropathies 2 Vascular Malformations 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Diseases, Vascular 1 Hyperglycemia 1 Hormone Receptor Positive Breast Carcinoma 1 Head and Neck Squamous Cell Cancer 1 Head and Neck Neoplasms 1 HER2-positive Metastatic Breast Cancer 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Arteriovenous Malformations 1 Advanced HER2+Breast Cancer 1 Advanced Breast Cancer 1

Interventions

pembrolizumab 27 Nivolumab 26 cabozantinib 25 Magnetic Resonance Spectroscopy 19 Specimen Handling 16 Ipilimumab 16 lenvatinib 10 belzutifan 7 atezolizumab 7 Biopsy 7 Axitinib 7 Sunitinib 6 Everolimus 6 CTLA-4 Antigen 6 avelumab 5 aldesleukin 5 Radiosurgery 5 Immunoglobulin G 5 Bevacizumab 5 pazopanib 4 fludarabine 4 Disulfides 4 Cyclophosphamide 4 zimberelimab 3 palbociclib 3 cemiplimab 3 Radiotherapy 3 Nephrectomy 3 IFL protocol 3 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡